DCMIC

Decheng Capital Management III (Cayman) Portfolio holdings

AUM $300M
This Quarter Return
+0.4%
1 Year Return
+15.94%
3 Year Return
5 Year Return
10 Year Return
AUM
$276M
AUM Growth
+$276M
Cap. Flow
+$24.6M
Cap. Flow %
8.92%
Top 10 Hldgs %
78.99%
Holding
28
New
3
Increased
5
Reduced
1
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALPN
1
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$48.3M 17.51% 6,708,288 +2,000,000 +42% +$14.4M
ZNTL icon
2
Zentalis Pharmaceuticals
ZNTL
$122M
$39.5M 14.33% 1,824,583
HLTH
3
DELISTED
Cue Health Inc. Common Stock
HLTH
$27M 9.8% 8,980,909
ILMN icon
4
Illumina
ILMN
$15.8B
$24.8M 9% 130,138 -24,100 -16% -$4.6M
RCUS icon
5
Arcus Biosciences
RCUS
$1.13B
$22.8M 8.25% 869,790
RXDX
6
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$14.8M 5.35% 250,000
ALBO
7
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$12.1M 4.38% 623,342 +105,000 +20% +$2.03M
TXG icon
8
10x Genomics
TXG
$1.74B
$10.2M 3.71% 359,554 +55,570 +18% +$1.58M
EQ icon
9
Equillium
EQ
$62.2M
$9.87M 3.58% 4,447,308
PACB icon
10
Pacific Biosciences
PACB
$393M
$8.51M 3.08% 1,463,872
ACET icon
11
Adicet Bio
ACET
$59.9M
$8.25M 2.99% 580,000
WHWK
12
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
$7.44M 2.7% 526,329
MRSN icon
13
Mersana Therapeutics
MRSN
$36.5M
$6.11M 2.22% 904,268
APGN
14
DELISTED
Apexigen, Inc. Common Stock
APGN
$5.12M 1.85% +1,894,551 New +$5.12M
BYSI icon
15
BeyondSpring
BYSI
$69.4M
$4.91M 1.78% 4,958,143 +1 +0% +$1
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.88M 1.77% 78,900 +23,500 +42% +$1.45M
TERN icon
17
Terns Pharmaceuticals
TERN
$609M
$4.21M 1.53% 714,285
AURA icon
18
Aura Biosciences
AURA
$389M
$3.81M 1.38% 210,000
SGEN
19
DELISTED
Seagen Inc. Common Stock
SGEN
$3.15M 1.14% +23,014 New +$3.15M
WGS icon
20
GeneDx Holdings
WGS
$3.72B
$3M 1.09% 3,418,929
ARGX icon
21
argenx
ARGX
$43.6B
$1.95M 0.71% +5,529 New +$1.95M
SCYX icon
22
SCYNEXIS
SCYX
$34.9M
$1.33M 0.48% 555,555
OWLT icon
23
Owlet
OWLT
$128M
$961K 0.35% 898,400
NAUT icon
24
Nautilus Biotechnolgy
NAUT
$85.9M
$636K 0.23% 300,000
NBSE
25
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$395K 0.14% 1,000,000